NCT01860742 2016-04-05
CASTOR
Jules Bordet Institute
Phase 3 Withdrawn
Clinical Trials
4 trialsNCT00293527 2013-05-23
Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma
Ohio State University Comprehensive Cancer Center
Phase 2 Withdrawn
NCT01409187 2012-01-26
IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT00963664 2009-09-09
Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma
NeoPlas Innovation
Phase 2 Withdrawn